Search Results 21-30 of 14319 for Assay
A Study to Refine and Modify the Granulocyte Antibody Test to Provide Patients the Most Sensitive and Accurate Blood Serum Assay Available. · Share · Facebook ...
... assays to those obtained by orthogonal methods, including tissue-based assays and results from a ctDNA assay by Guardant on blood. Participation eligibility.
Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol · Overview · Participation eligibility · Participating Mayo Clinic ...
Novel MOG assay aids diagnosis of demyelinating diseases · Mayo Clinic has developed the first test available in the US to identify the myelin oligodendrocyte ...
... assay for the detection of mutations associated with uveal melanoma. The performance characteristics of the ddPCR assay for the detection of ctDNA mutation ...
To evaluate the ability of the plasma MDM assay to predict CRC recurrence when tested serially following curative resection of CRC metastases. Participation ...
If the test is available on an existing platform in the Targeted Biomarker Core, the core can perform the assay if the number of samples is sufficient and with ...
The purpose of this study is to validate an internally developed assay for the detection of BRAF V600E mutations in cfDNA from the peripheral blood of patients ...
Development and Validation of Newborn Screening Assays to Measure Biomarkers and Enzyme Levels in Biological Samples from Patients with a Lysosomal Storage ...
The purpose of this study is to explore the clinical utility of routinely measuring thymidine kinase activity (TKa) in HR+ metastatic breast cancer patients ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.